Literature DB >> 17437433

'Skipping' is still a problem with radiofrequency ablation of small renal tumours.

H Christoph Klingler1, Michael Marberger, Julian Mauermann, Mesut Remzi, Martin Susani.   

Abstract

OBJECTIVE: To evaluate the homogeneity and extent of necrosis obtained with next-generation radiofrequency ablation (RFA) equipment and techniques, as incomplete tumour necrosis, or 'skipping', has been documented after RFA of renal tumours and subsequent partial nephrectomy, but this was assumed to result from insufficient energy deposition with first-generation low-energy generators. PATIENTS AND METHODS: In all, 17 patients with solitary renal tumours of <or=4 cm were treated with RFA under laparoscopic control. A state-of-the-art monopolar RFA generator and 15 G multi-tined needle probes were used. The probe tines were deployed to create an ablation zone>0.5-1.0 cm beyond the sonographically controlled tumour borders. Target temperatures of 105 degrees C were applied in three cycles for 10-30 min at up to 150 W. Tumours were then removed by laparoscopic partial nephrectomy and specimens evaluated by detailed histology.
RESULTS: The mean (range) resected tumour size was 22 (11-40) mm, the mean RFA time was 39 (27-59) min and the mean surgical resection time was 25 (12-45) min. In 13 patients, haemostasis was sufficient to avoid the renal pedicle being clamped. Intraoperative repeated positive margins in one patient required a laparoscopic radical nephrectomy. Thirteen (76%) renal masses showed histologically complete ablation of the entire tumour. Of the four RFA failures, three tumours were >3 cm in diameter, two were highly vascularized and three had a very heterogeneous tissue texture.
CONCLUSION: Even with state-of-the-art technology, skipping remains a problem with RFA for small renal masses and renders the technique unreliable.

Entities:  

Mesh:

Year:  2007        PMID: 17437433     DOI: 10.1111/j.1464-410X.2007.06769.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  12 in total

Review 1.  Management of small renal masses: a review.

Authors:  Mesut Remzi; Elchin Javadli; Mehmet Ozsoy
Journal:  World J Urol       Date:  2010-02-23       Impact factor: 4.226

2.  [Small renal cell carcinoma-active surveillance and ablation].

Authors:  J J Wendler; R Damm; U-B Liehr; T Brunner; M Pech; M Schostak
Journal:  Urologe A       Date:  2018-06       Impact factor: 0.639

3.  Clinical efficacy of bipolar radiofrequency ablation of small renal masses.

Authors:  S G C Kroeze; M Agenant; G N Jonges; T Stein; J L H R Bosch
Journal:  World J Urol       Date:  2014-10-29       Impact factor: 4.226

4.  Ablative therapies for renal tumors.

Authors:  Rajan Ramanathan; Raymond J Leveillee
Journal:  Ther Adv Urol       Date:  2010-04

Review 5.  [Energy ablative therapy of renal tumours].

Authors:  H C Klingler
Journal:  Urologe A       Date:  2007-05       Impact factor: 0.639

6.  Partial nephrectomy after previous radio frequency ablation: the National Cancer Institute experience.

Authors:  Keith J Kowalczyk; H Brooks Hooper; W Marston Linehan; Peter A Pinto; Bradford J Wood; Gennady Bratslavsky
Journal:  J Urol       Date:  2009-09-16       Impact factor: 7.450

Review 7.  [Focal therapy for small renal masses : Observation, ablation or surgery].

Authors:  J J Wendler; B Friebe; D Baumunk; A Blana; T Franiel; R Ganzer; B Hadaschik; T Henkel; K U Köhrmann; J Köllermann; T Kuru; S Machtens; A Roosen; G Salomon; H P Schlemmer; L Sentker; U Witzsch; U B Liehr; J Ricke; M Schostak
Journal:  Urologe A       Date:  2016-05       Impact factor: 0.639

8.  Radiofrequency ablation of renal tumours with clinical, radiographical and pathological results.

Authors:  Jose A Karam; Kamran Ahrar; Raghunandan Vikram; Claudio A Romero; Eric Jonasch; Nizar M Tannir; Priya Rao; Christopher G Wood; Surena F Matin
Journal:  BJU Int       Date:  2013-03-19       Impact factor: 5.588

9.  Partial nephrectomy and enbloc liver resection using a bipolar radiofrequency device for renal cell carcinoma invading the liver.

Authors:  M Pitchaimuthu; M Pai; N A Habib
Journal:  BMJ Case Rep       Date:  2010-10-28

10.  Current and future technology for minimally invasive ablation of renal cell carcinoma.

Authors:  Branden G Duffey; J Kyle Anderson
Journal:  Indian J Urol       Date:  2010-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.